Introduction
The incidence of infantile haemangiomas is 5%to10%oflight-skinnedchildrenandthey are the most common soft-tissue tumours of infancy (Walteretal,1999) .Theyoccurmostly withinthefirstyearoflifeandfemaleinfants are three to four times more likely to suffer from haemangioma as male infants (Frieden etal,2005) . Haemangiomasareneoplasticproliferations ofendothelialcells,whichgrowafterbirthand regressspontaneously (MendirattaandJabeen, 2010) and only a few need to be treated systemically. However, 10% of the infantile haemangiomasneedtobetreatedduringthe proliferativephase,aslocalcomplicationssuch as ulceration, haemorrhage and necrosis can leadtoscarsthataredifficulttorepair (Enjolras and Gelbert, 1997) . The haemangiomas can lead to deformities when they are located in areas of the lip, nasal tip or the ear, and caneven belife-threatening whenpresentin upperairwaysandtheliverbyinducingacute respiratoryfailureandcongestiveheartfailure (PopeandChakkittakandiyil,2010) .
Forthetherapyofinfantilehaemangiomas, propranolol, a non-selective beta blocker, has whichincludedanelectrocardiographyaswell as the measurement of blood pressure, was inconspicuous.
Results
Propranolol was applied at a dosage of 8 mg/day orally for a period of 4 weeks. Before the start of the therapy, pictures of the haemangioma were taken. After 2 and 4 weeks,theparentspresentedtheirbabyfora follow-upandagainpicturesweretaken.
The pictures were presented to two independent paediatricians with the request foranobjectiveassessment.Bothpaediatricians confirmedasignificantchangeincolourfrom darkredtoalightershadeofredandpartially eventoskincolour( Figure 1) 
Discussion
The vast majority of infantile haemangiomas do not require any medical or surgical intervention. Medical care of clinically significant haemangiomas has been limited to a few medications, including glucocorticosteroids(topical,intralesionaland oral), interferon alpha and, rarely, vincristine andtopicalimiquimod.
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proventobeaneffectivetreatmentalternative to corticosteroids or interferon, which have many potential side-effects. The suspected therapeutic effects of propranolol in infantile haemangiomas are vasoconstriction, and decreased expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) genes by downregulating the Raf/mitogen-activated protein kinasepathwayandtheapoptosisofcapillary endothelialcells (KhungerandPahwa,2011) .
We present a case of a 4-month-old baby born with a large infantile haemangioma of the shoulder, which was treated successfully withoralpropranolol.
Patient and methods
Ababyattheageof4monthswithinfantile superficial haemangioma was presented in our paediatric day centre.The haemangioma extendedoverthewholeleftshoulderandhad a dark red colour. After obtaining informed consent from the parents, treatment with propranololwascommenced(8 mg/dayover 4 weeksorallyassingledailydose).At4weeks, a picture of the haemangioma was taken (Figure 1) . A physical examination was done before thestartofthetherapyandthebloodpressure was taken.There was no contraindication to the treatment. The follow-up examination, Since 2008, topical and oral beta blockers have been used to treat infantile haemangioma as'off-label use'. Beta blockers have serendipitously been shown to induce involution of infantile haemangiomas and many reports have described the early regressionofinfantilehaemangiomasafteroral or systemic Beta blocker treatment (Lawley et al, 2009; Guo and Ni, 2010; Pope and Chakkittakandiyil,2010; KhungerandPahwa, 2011; Nietal,2011; Weissensteinetal,2012a; Weissensteinetal,2012b ).
An expert panel has developed provisional recommendations for the use of topical beta blockers, including in patients with PHACE syndrome (posterior fossa abnormalities, haemangioma, arterial lesions, cardiac abnormalities/aortic coarctation and eye abnormalities) (Khunger and Pahwa, 2011) . PHACEsyndromeisassociatedwithahigher riskofneurologicalandcognitiveimpairment (Khunger and Pahwa, 2011) . Pope and Chakkittakandiyil (2010) described a series ofsixchildrenandNietal(2011)described seven children with superficial capillary haemangiomas of the eyelid. All children were treated successfully with timolol gel as a form of topical beta blocker and no sideeffectshaveoccurredinthesestudies.In2012, Weissenstein et al (2012a Weissenstein et al ( , 2012b reported twice about the early regression of infantile haemangioma.
Different authors have discovered the positiveeffectoforalbetablockersinasmall study group. Guo and Ni (2010) described a caseofachildwithacapillaryhaemangioma. However, Lawley et al (2009) have reported on the side-effects of propranolol, such as hypoglycemia, bradycardia and hypotension. Blood sugar, electrocardiogram and blood pressure were proven before starting the therapy (Lawley et al, 2009 ). However, it is known that for children it is necessary to obtain the permission from both parents and anethicscommission.
It is very important to underline the need for caution with the off-label use of oral and systemic beta blockers in the treatment of infantile haemangioma. The results are promising and clear guidelines from paediatricians are necessary and to anticipate [AQ3:anticipatewhat?]
Conclusion
Theuseoftopicalandoralbetablockersseems to be the treatment of choice for infantile haemangiomaforthefuture.Weareconfident that [AQ4: OK? Originally, you wrote'will', which sounded strange if the studies haven't yet been done yet] controlled trials with a largenumberofcaseswilldeliveraconclusion thatbetablockersarethefirstchoicetherapy ininfantilehaemangioma.
